Abstract:Circulation, Volume 146, Issue Suppl_1, Page A15700-A15700, November 8, 2022. Cardiac fibroblasts acquire inflammatory, proangiogenic, or matrix-synthetic phenotypes following MI and play a pivotal role in repair and remodeling of the infarcted heart. Members of the Transforming Growth Factor (TGF)β superfamily (including TGFβs and BMPs) are activated following MI and regulate fibroblast phenotype and cardiac fibrosis. Canonical TGFβ signaling is mediated through the receptor-activated Smads: TGF-βs activate Smad2/3, whereas BMPs predominantly stimulate Smad1/5 cascade. Smad3 signaling plays an important role in activation of infarct myofibroblasts; however, the role of the Smad1 pathway remains unknown. We hypothesized that fibroblast-specific actions of Smad1 regulate repair and remodeling in the infarcted myocardium. In a mouse model of non-reperfused infarction, Smad1 was activated in a subset of cardiac myofibroblasts not only by BMPs, but also by all three TGF-β isoforms. TGF-β activation of Smad1 was dependent on both ALK1 and ALK5 signaling. Analysis of single cell RNA-seq data suggested that ALK1 is a marker of a myofibroblast subset exhibiting anti-fibrotic properties. In order to examine the role of fibroblast Smad1 in vivo, we generated mice with myofibroblast-specific Smad1 loss (MFS1KO). Echocardiography showed that MFS1KO mice have accentuated systolic dysfunction and LV dilation 7-28 days after MI(p<0.01, N=13-49). Worse adverse remodeling in infarcted MFS1KO hearts was associated with scar expansion, higher myofibroblast density and accentuated fibrosis. Smad1 knockdown in cardiac fibroblasts increased mRNA levels of structural and matricellular genes while reducing matrix metalloproteinase synthesis. RNA-seq showed that Smad1 loss activates pathways involved in matrix regulation and collagen biosynthesis, and suggested that Smad1 may exert anti-fibrotic actions through inhibition of TGF-β/Smad3 axis, p53, and IL4/STAT6 pro-fibrotic cascades. In conclusion, Smad1 activation in a subset of anti-fibrotic infarct myofibroblasts restrains cardiac fibrosis and protects from adverse remodeling by inhibiting key pro-fibrotic pathways. These findings suggest that Smad1 activation in fibroblasts may be a promising strategy to restrain cardiac fibrosis in infarcted and failing hearts.

Antifibrotic Properties of C-Ski and Its Regulation of Cardiac Myofibroblast Phenotype and Contractility.

PCSK9 Regulates Myofibroblast Transformation Through the JAK2/STAT3 Pathway to Regulate Fibrosis after Myocardial Infarction.

Cathepsin S-mediated Fibroblast Trans-Differentiation Contributes to Left Ventricular Remodelling after Myocardial Infarction.

Inhibition of the Hedgehog Pathway Leads to Antifibrotic Effects in Dermal Fibrosis

Effect of fibroblasts small- conductance Ca2+ -activated potassium channel subtype 2 (SK2) on myocardial fibrosis in pressure overload mouse

Abstract 363: Resident Vascular Adventitial Progenitor Cells Of Smooth Muscle Cell-lineage Adopt Profibrotic Phenotype And Contribute To Cardiac Fibrosis.

The Mir-214-3p/c-ski Axis Modulates Endothelial–mesenchymal Transition in Human Coronary Artery Endothelial Cells in Vitro and in Mice Model in Vivo

Decreased phosphorylation facilitates the degradation of the endogenous protective molecule c-Ski in vascular smooth muscle cells

Abstract 317: Resident Vascular Adventitial Progenitor Cells Of Smooth Muscle Cell-lineage Adopt Profibrotic Phenotype And Contribute To Cardiac Fibrosis

Therapeutic Targeting of Src Kinase and Myofibroblast Activation in Pulmonary Fibrosis

Abstract 230: Cartilage Intermediate Layer Protein-1 Attenuates Pressure Overload-induced Cardiac Fibrosis by Targeting Transforming Growth Factor-β1

Abstract 11470: Functional Validation of the Novel Role of SMARCB1 in Myocardial Fibrosis

Abstract 15700: ALK1-Mediated Smad1 Activation in a Myofibroblast Subset Protects the Infarcted Heart From Adverse Remodeling and Excessive Fibrosis

Matricellular Protein Cilp1 Promotes Myocardial Fibrosis in Response to Myocardial Infarction

CTRP15 Derived from Cardiac Myocytes Attenuates TGFβ1-induced Fibrotic Response in Cardiac Fibroblasts.

SNRK regulates TGFbeta levels in atria to control cardiac fibrosis

Antifibrotic effects of crocetin in scleroderma fibroblasts and in bleomycin-induced sclerotic mice

Connective Tissue Growth Factor Expression And Smad Signaling During Mouse Heart Development And Myocardial Infarction

Attenuation of Expression of Extracellular Matrix Genes with Sirnas to SPARC and CTGF in Skin Fibroblasts of CTGF Transgenic Mice

Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's - derived fibroblasts

PCSK9 Inhibition Regulates Infarction-Induced Cardiac Myofibroblast Transdifferentiation via Notch1 Signaling